Limbach still screens as a profitable, cash-generative small-cap industrial with ODR mix, data-center demand and manageable leverage. The Q2 2026 margin miss, lowered EBITDA guide and shareholder investigations make this a disciplined re-rating setup, not a clean compounder.
EV/EBITDA is used because LMB is profitable and guidance-driven. The target multiple is derived from peer median, not reverse-engineered from a target price: peer median EV/EBITDA near 16.7x, adjusted down 34% for size, Q2 margin reset, M&A and legal overhang. Sensitivity: every 1x multiple on ~$92M pro-forma EBITDA is about $7.7/sh; +/-2x moves FV roughly +/-21%, inside the reported range. Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Legacy Limbach operating EV | $81M FY2026E adjusted EBITDA midpoint x 11.0x EV/EBITDA / 11.92M shares | +74.75 |
| 1901 Inc. operating EV | $11M 2027E adjusted EBITDA x 8.5x EV/EBITDA / 11.92M shares | +7.84 |
| CYMCOR / data-center option | 35% probability x $45M platform value from data-center services / 11.92M shares | +1.32 |
| Pro-forma net debt | ~$93M estimated net debt after $30M CYMCOR + $63M 1901 cash purchases / 11.92M shares | -7.80 |
| Integration and litigation reserve | -$25M reserve for 1901/CYMCOR integration, margin remediation and legal-investigation friction / 11.92M shares | -2.10 |
| FV base case | Explicit sum: 74.75 + 7.84 + 1.32 - 7.80 - 2.10 = $74.01, rounded to $74.00 | $74.00 |
Insider trading check: third-party Form 4 trackers show 12-month insider sales around $3.69M versus purchases around $516K, including CFO Jayme Brooks selling more than $1.5M across March-April 2026 and EVP Jay Sharp selling about $644K in June and September. This is material because it overlaps the post-Q2 investigation period, even though some trades may be planned or compensation-related.
| Item | FY2023 | FY2024 | FY2025 | TTM Jun 2026 | Guidance / note |
|---|---|---|---|---|---|
| Revenue | $516.4M | $518.8M | $646.8M | $683.8M | FY2026: $760-$790M |
| Gross profit | $119.3M | $144.3M | $169.3M | $161.2M | FY2026 gross margin: 23%-24% |
| Operating income | $30.0M | $42.4M | $51.4M | $40.4M | Q2 pressure from margin reset |
| Net income | $20.8M | $30.9M | $39.1M | $30.2M | Positive, but down TTM |
| Free cash flow | $55.1M | $29.3M | $41.9M | $50.6M | FY2026 guide: ~75% of EBITDA |
| Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 142.2 | 184.6 | N/D | 138.9 | 173.5 |
| Gross margin % | 28.0% | 24.2% | N/D | 22.5% | 21.5% |
| Net income ($M) | 7.8 | N/D | N/D | 4.4 | 4.7 |
| Cash EOP ($M) | 39.0 | N/D | 11.4 | N/D | 17.5 |
Business model - owner-direct building systems platform
Owner Direct Relationships $128.4M Q2 2026 (74% of rev) core Higher-quality revenue stream with service/retrofit content. Q2 ODR gross margin fell to 24.0%, so re-expansion is essential. General Contractor Relationships $45.0M Q2 2026 (26% of rev) lower margin Still useful scale and backlog, but Q2 GCR margin at 14.5% shows why the mix transition matters. Acquired platforms 1901: $140M revenue / $11M EBITDA 2027E integration CYMCOR adds data-center services; 1901 adds Midwest MEPC scale. Both need integration discipline to protect returns.
Legal, regulatory and risk analysis
SWOT analysis
- +ODR mix reached 74.0% of Q2 revenue.
- +Positive earnings and FCF separate LMB from speculative small caps.
- +Data-center, healthcare and mission-critical facilities are resilient verticals.
- −Q2 2026 margin miss damaged the quality narrative.
- −Small scale limits multiple parity with FIX/EME/IESC.
- −Insider net selling is a governance optics issue.
- →Q3 results can prove Q2 was timing and mix, not structural deterioration.
- →1901 expands Midwest electrical/MEPC capabilities.
- →Multiple can move toward peers if EBITDA recovers.
- !Investigations could become formal litigation.
- !Integration costs could absorb acquisition EBITDA.
- !Labor and material competition in data-center markets can keep margins under pressure.
Summary by assessment area
- Positive FCF, ODR mix and low pre-deal leverage support the factor screen.
- Quality status depends on Q3/Q4 margin recovery.
- Base FV of $74 implies +43.8% from $51.48.
- Consensus target of $77.20 is close to the internal base case.
- Law-firm investigations and insider selling cap near-term multiple expansion.
- Acquisitions must not mask margin weakness.
Sources: StockAnalysis LMB price/statistics/financials/forecast pages, SEC Exhibit 99.1 Q2 2026 and Q1 2026 releases, Limbach 1901 acquisition release, MarketBeat and Benzinga short-interest pages, InsiderFlow / Levi & Korsinsky insider transaction summaries, Pomerantz / SBS / Bronstein shareholder-investigation notices, peer statistics from StockAnalysis for MYRG, EME, IESC and FIX. Market data as of Sep 25, 2026: LMB $51.48 close, after-hours $51.51, market cap ~$613.9M, EV ~$656.0M, 52W range $40.74-$114.95, shares outstanding 11.92M, latest short interest 963,979 shares / 8.69% of float / 1.92 days to cover. Price row used: LMB ~$51.48 at close Sep 25, 2026; cross-check MarketBeat showed ~$51.11 intraday and $50.52 short-interest record price on Sep 15, 2026, inside the 52W range and consistent with $613.9M market cap / 11.92M shares. This document is for informational purposes only and does not constitute financial or investment advice.